News Release: Experimental HIV vaccine regimens likely to be ineffective in preventing HIV acquisition, PrEPVacc study reports IMPERIAL, MRC CTU at UCL, MRC/UVRI and LSHTM Uganda, MUHAS, NIMR-MMRC, SAMRCPrEP Vacc4 December 2023
News Release: African-led PrEPVacc HIV prevention study completes its enrolment IMPERIAL, INS, MRC CTU at UCL, MRC/UVRI and LSHTM Uganda, MUHAS, NIMR-MMRC, SAMRCPrEP Vacc9 June 2023
Video to help inform PrEPVacc participants posted online IMPERIAL, MRC CTU at UCL, MRC/UVRI and LSHTM Uganda, MUHAS, NIMR-MMRC, SAMRCPrEP Vacc31 March 2023
PrEPVacc featured in JIAS articles in Nov 2021 IMPERIAL, INS, MRC CTU at UCL, MRC/UVRI and LSHTM Uganda, MUHAS, NIMR-MMRC, SAMRCPrEP Vacc30 November 2021
PrEPVacc welcomes results of HPTN 084 injectable PrEP study MRC CTU at UCL, SAMRCPrEP Vacc11 November 2020
PrEPVacc leaders contribute to future design of HIV prevention trials MRC/UVRI and LSHTM Uganda, MRC CTU at UCLPrEP Vacc6 November 2020
Pontiano Kaleebu and Sheena McCormack named Co-Chairs for HIVR4P 2020 MRC/UVRI and LSHTM Uganda, MRC CTU at UCLPrEP Vacc21 February 2019
